Aveanna Healthcare Holdings, Inc. (AVAH) Stock Price & Analysis
Aveanna Healthcare Holdings, Inc. (AVAH) rose 4.07% to USD 9.45 as of July 25, 2026 at 06:43 UTC, according to Nexqual real-time market data.
AVAH last closed at USD 9.08; the session ranged USD 9.24–9.69 on volume of 2,918,233 shares. Market capitalization is $2.06B, with a 52-week range of USD 3.73–10.32 (NMS). Source: Nexqual, July 25, 2026 at 06:43 UTC.
Key Statistics (as of July 25, 2026 at 06:43 UTC)
| Price | USD 9.45 |
|---|---|
| Change | ▲ 4.07% (up) |
| Previous Close | USD 9.08 |
| Open | USD 9.32 |
| Day Range | USD 9.24 – 9.69 |
| 52-Week Range | USD 3.73 – 10.32 |
| Volume | 2,918,233 shares |
| Market Cap | $2.06B |
| Exchange | NMS |
Technical Analysis (AVAH)
Nexqual's technical model rates AVAH "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 06:43 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.23 (neutral) |
| vs SMA50 | Above (USD 8.15) |
| MACD | 0.41 (positive) |
Analyst Ratings (AVAH)
Wall Street analysts rate AVAH "Buy" based on 10 analysts, with a mean price target of USD 10.45 (range USD 8–13), per Nexqual as of July 25, 2026 at 06:43 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 10 |
| Mean Target | USD 10.45 |
| High Target | USD 13 |
| Low Target | USD 8 |
| Buy / Hold / Sell | 8 / 3 / 0 |
Earnings (AVAH)
| Next Earnings Date | 2026-08-13 |
|---|---|
| EPS Estimate | USD 0.17 |
| Revenue Estimate | $638.63M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.18 vs est 0.13 ▲ beat |
| 2025-12-31 | USD 0.17 vs est 0.16 ▲ beat |
| 2025-09-30 | USD 0.15 vs est 0.13 ▲ beat |
| 2025-06-30 | USD 0.18 vs est 0.04 ▲ beat |
Source: Nexqual, July 25, 2026 at 06:43 UTC.
Financials & Fundamentals (AVAH)
| Total Revenue | $2.52B |
|---|---|
| Revenue Growth (YoY) | +15.90% |
| Gross Margin | +32.76% |
| Operating Margin | +11.18% |
| Profit Margin | +10.37% |
| ROE | +368.01% |
| Debt / Equity | 623.92 |
| Current Ratio | 1.47 |
| Total Cash | $197.27M |
| Total Debt | $1.50B |
| Free Cash Flow | $82.58M |
Source: Nexqual, July 25, 2026 at 06:43 UTC.
Financial Health Score (AVAH)
Nexqual rates Aveanna Healthcare Holdings, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 06:43 UTC.
| Growth | Strong — Revenue +20% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 33%, operating 11% |
| Balance Sheet | Critical — $197M cash vs $1.50B debt |
| Cash Flow | Mixed — FCF $83M, slim 3.4% margin |
| Efficiency | Strong — ROE 368%, ROA 10.2% |
Ownership (AVAH)
| Insider Ownership | +5.80% |
|---|---|
| Institutional Ownership | +92.03% |
| Shares Outstanding | 217.76M |
| Float | 86.95M |
| Short % of Float | +5.07% |
Source: Nexqual, July 25, 2026 at 06:43 UTC.
Leadership (AVAH)
Aveanna Healthcare Holdings, Inc. is led by Jeffrey S. Shaner (age 52), President, CEO & Director, per Nexqual as of July 25, 2026 at 06:43 UTC.
| President, CEO & Director | Jeffrey S. Shaner (age 52) |
|---|---|
| Executive Chairman | Rodney D. Windley (age 77) |
| CFO & Principal Financial Officer | Matthew Buckhalter (age 36) |
| Chief Operating Officer | Kristy Rohwedder |
| President of Home Health & Hospice | Shane Brinkerhoff |
Major Backers & Investors (AVAH)
Notable institutional backers of Aveanna Healthcare Holdings, Inc. include Bain Capital Investors Llc, J.H. Whitney Equity Partners VII, LLC, Nut Tree Capital Management, LP, according to Nexqual as of July 25, 2026 at 06:43 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Bain Capital Investors Llc | 37.47% |
| J.H. Whitney Equity Partners VII, LLC | 16.64% |
| Nut Tree Capital Management, LP | 5.93% |
| Summit Partners, L.P. | 2.5% |
| Boston Partners | 1.3% |
| Littlejohn & Co LLC | 1.01% |
| Braidwell LP | 1.01% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 3.61% |
| BlackRock | 3.13% |
| Nuveen | 1.01% |
Source: Nexqual, July 25, 2026 at 06:43 UTC.
From Aveanna Healthcare Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States.
- Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
- The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS).
- The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BVS | Bioventus Inc. | USD 11.8 | ▲ 1.46% |
| PRVA | Privia Health Group, Inc. | USD 25.5 | ▲ 0.51% |
| ALHC | Alignment Healthcare, Inc. | USD 19.43 | ▼ 6.45% |
| LFST | LifeStance Health Group, Inc. | USD 10.9 | ▼ 1% |
| DSGN | Design Therapeutics, Inc. | USD 11.78 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:43 UTC. This page is informational and not investment advice.